Sector
PharmaceuticalsOpen
₹453.5Prev. Close
₹453.1Turnover(Lac.)
₹15.98Day's High
₹456.65Day's Low
₹449.5552 Week's High
₹84552 Week's Low
₹355.45Book Value
₹165.53Face Value
₹10Mkt Cap (₹ Cr.)
577.62P/E
43.47EPS
10.46Divi. Yield
0.2221 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
8 Aug 2023
12:00 AM
AGM
Announcement Date: 08 Aug, 2023
8 Aug 2023
12:00 AM
BookCloser
29 May 2023
12:00 AM
Dividend
Dividend Amount: 1
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 13.78 | 12.22 | 12.22 | 12.22 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 180.02 | 135.82 | 122.14 | 110.26 |
Net Worth | 193.8 | 148.04 | 134.36 | 122.48 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 110.14 | 117.34 | 111.5 | 82.45 |
yoy growth (%) | -6.13 | 5.23 | 35.23 | 22.56 |
Raw materials | -66.87 | -72.95 | -67.65 | -49.2 |
As % of sales | 60.71 | 62.17 | 60.67 | 59.67 |
Employee costs | -8.79 | -9.29 | -9.05 | -6.65 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 16.75 | 16.6 | 13.9 | 6.35 |
Depreciation | -2.51 | -2.49 | -2.05 | -1.92 |
Tax paid | -4.26 | -4.34 | -3.78 | -1.19 |
Working capital | -1.38 | -8.09 | 38.28 | 6.51 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -6.13 | 5.23 | 35.23 | 22.56 |
Op profit growth | 10.23 | 7.79 | 49.71 | 119.69 |
EBIT growth | 3.74 | 5.29 | 73.66 | 146.26 |
Net profit growth | 1.85 | 21.22 | 95.97 | 973.02 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 179.31 | 140.87 | 115.45 | 112.72 | 125.5 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 179.31 | 140.87 | 115.45 | 112.72 | 125.5 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.33 | 2.46 | 1.72 | 0.75 | 1.94 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Sanjay Bansal
Chairman (Non-Executive)
Rahul Bishnoi
Non Executive Director
Ashwani Kumar Sharma
Independent Director
Harish Pande
Non Executive Director
S K Singh
Independent Director
Arun Kumar
Company Sec. & Compli. Officer
Parul Choudhary
Independent Director
Sumita Dwivedi
Non Executive Director
Vimal Kumar Shrawat.
Independent Director
Sangeeta Bishnoi
Independent Director
Ravi Kumar Bansal
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Medicamen Biotech Ltd
Summary
Medicamen Biotech Ltd is a widely held, Globally Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. The company is engaged in manufacture and distribution of medicines. They manufacturer and supply the range of products such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non beta lactum) and ointment. The company has two manufacturing facilities namely, Bhiwadi (Rajasthan) and Haridwar (Uttarakhand). The Bhiwadi unit has ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and hardworking workforce. In Haridwar unit, the company manufactures Non-Betalactum preparations including tablets, capsules, oral liquids and ointments & creams.The company is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical Fraternity.Medicamen Biotech Ltd was incorporated on December 1993 and started their operation as distributor and manufacturer of medicines on loan license basis. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries.The vast distribution network with demand for low cost medicines prompted the company to go for own manufacturing facilities. Thus, in the year 1994, a lan
Read More
What is the Medicamen Biotech Ltd share price today?
The Medicamen Biotech Ltd shares price on N/A is Rs.₹453.95 today.
What is the Market Cap of Medicamen Biotech Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Medicamen Biotech Ltd is ₹577.18 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Medicamen Biotech Ltd?
The PE and PB ratios of Medicamen Biotech Ltd is 43.47 and 2.76 as of 22 Jul ‘24
What is the 52 Week High and Low of Medicamen Biotech Ltd?
The 52-week high/low is the highest and lowest price at which a Medicamen Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Medicamen Biotech Ltd is ₹356.75 and ₹903.5 as of 22 Jul ‘24
What is the CAGR of Medicamen Biotech Ltd?
Medicamen Biotech Ltd's CAGR for 5 Years at 2.17%, 3 Years at -8.24%, 1 Year at -41.07%, 6 Month at -18.12%, 3 Month at 9.09% and 1 Month at -3.16%.
What is the shareholding pattern of Medicamen Biotech Ltd?
The shareholding pattern of Medicamen Biotech Ltd is as follows:
Promoters - 42.99 %
Institutions - 1.23 %
Public - 55.78 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
